References of Table 3 in Supplementary material
60. Rubboli A, Colletta M, Sangiorgio P, et al. Antithrombotic strategies in patients with an indication for long-term
anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center. Ital Heart J
2004, 5:919–925.
61. Orford JL, Fasseas P, Melby S, et al. Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent
placement in patients with an indication for anticoagulation. Am Heart J 2004, 147:463–467.
62. Mattichack SJ, Reed PS, Gallagher MJ, et al. Evaluation of safety of warfarin in combination with antiplatelet
therapy for patients treated with coronary stents for acute myocardial infarction. J Interven Cardiol 2005, 18:163–
166.
63. Lip GYH, Karpha M. Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing
percutaneous coronary intervention: the need for consensus and a management guideline. Chest 2006, 130:1823–
1827.
64. Khurram Z, Chou E, Minutello R, et al. Combination therapy with aspirin, clopidogrel and warfarin following
coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 2006, 18(4):162–164.
65. Porter A, Konstantino Y, Iakobishvili Z, et al. Short-term triple therapy with aspirin, warfarin, and a
thienopyridine among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2006,
68:56–61.
66. Konstantino Y, Iakobishvili Z, Porter A, et al. Aspirin, warfarin and a thienopyridine for acute coronary
syndromes. Cardiology. 2006;105(2):80-5.
67. Rubboli A, Colletta M, Herzfeld J, et al. Periprocedural and medium-term antithrombotic strategies in patients
with an indication for long-term anticoagulation undergoing coronary angiography and intervention. Coron Artery
Dis 2007, 18:193–199.
68. DeEugenio D, Kolman L, DeCaro M, et al. Risk of major bleeding with concomitant dual antiplatelet therapy
after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacoherapy 2007,
27(5):691–696.
69. Nguyen MC, Lim YL, Walton A, et al. Combining warfarin and antiplatelet therapy after coronary stenting in the
Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent? Eur Heart J
2007, 28:1717–1722.
70. Valencia J, Mainar V, Bordes P, et al. Observance of Antiplatelet Therapy after Stent Implantation in Patients
under Chronic Oral Anticoagulant Treatment. J Interven Cardiol 2008, 21:218–224.
71. Rossini R, Musumeci G, Lettieri C, et al. Long-term outcomes in patients undergoing coronary stenting on dual
oral antiplatelet treatment requiring oral anticoagulant therapy. Am J Cardiol. 2008 Dec 15;102(12):1618-23.
72. Manzano-Fernandez S, Pastor FJ, Marin F, et al. Increased major bleeding complications related to triple
antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting.
Chest 2008, 134(3):559–567.
73. Rogacka R, Chieffo A, Michev I, et al. Dual antiplatelet therapy after percutaneous coronary intervention with
stent implantation in patients taking chronic oral anticoagulation. JACC Cardiovasc Interv 2008, 1(1):56–61.
74. Maegdefessel L, Schlitt A, Faerber J, et al. Anticoagulant and/or antiplatelet treatment in patients with atrial
fibrillation after percutaneous coronary intervention. A single-center experience. Med Klin (Munich) 2008,
103(9):628–632.
75. Rossini R, Musumeci G, Lettieri C, et al. Outcomes of long-term triple therapy with aspirin, clopidogrel, and
warfarin in patients undergoing coronary stenting [abstract]. Eur Heart 2008, 29(Suppl):328.
76. Ruiz-Nodar JM, Marin F, Hurtado JA, et al. Anticoagulant and antiplatelet therapy use in 426 patients with atrial
fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk
and prognosis. J Am Coll Cardiol 2008, 51(8):818–825.
77. Sarafoff N, Ndrepepa G, Mehilli J, et al. Aspirin and clopidogrel with or without phenprocoumon after drug
eluting coronary stent placement in patients on chronic oral anticoagulation. J Intern Med 2008, 264:472–480.
78. Karjalainen PP, Vikman S, Niemelä M, et al. Safety of percutaneous coronary intervention during uninterrupted
oral anticoagulant treatment. Eur Heart J. 2008 Apr; 29(8):1001-10.
79. Wang TY, Robinson LA, Ou FS, et al. Discharge antithrombotic strategies among patients with acute coronary
syndrome previously on warfarin anticoagulation: physician practice in the CRUSADE registry. Am Heart J. 2008
Feb;155(2):361-8.
80. Helft G, Dambrin G, Zaman A, et al. Percutaneous coronary intervention in anticoagulated patients via radial
artery access. Catheter Cardiovasc Interv 2009, 73:44–47.
81. Halbfass P, Janko S, Dorwarth U, et al. Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation
patients squeezed between thrombosis and bleeding events: a single-center experience. Europace 2009, 11:957–
960.
82. Olson KL, Delate T, Johnson SG, et al. Incidence of hemorrhage among anticoagulated patients receiving
antiplatelet therapy after percutaneous coronary intervention. J Thromb Thrombolysis 2009, 29:316–321.
83. Gilard M, Blanchard D, Helft G, et al. Antiplatelet therapy in patients with anticoagulants undergoing
percutaneous coronary stenting (from STENTIng and oral antiCOagulants [STENTICO]). Am J Cardiol 2009,
104(3):338–342.
84. Sambola A, Ferreira-González I, Angel J, et al. Therapeutic strategies after coronary stenting in chronically
anticoagulated patients: the MUSICA study. Heart 2009, 95(18):1483–1488.
85. Baber U, Akhter M, Kothari S, et al. Efficacy of modified dual antiplatelet therapy combined with warfarin
following percutaneous coronary intervention with drug-eluting stents. J Invasive Cardiol 2010, 22:80–83.
86. Hälg C, Brunner-La Rocca HP, Kaiser C, et al. Early and late increased bleeding rates after angioplasty and
stenting due to combined antiplatelet and anticoagulant therapy. Euro Intervention 2009, 5:425–431.
87. Uchidab Y, Mori F, Ogawa H, et al. Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis
after treatment with drug-eluting coronary stents. J Cardiol 2010, 55:362–369.
88. Gao F, Zhou YJ, Wang ZJ, et al. Comparison of Different Antithrombotic Regimens for Patients With Atrial
Fibrillation Undergoing Drug-Eluting Stent Implantation. Circ J 2010, 74:701–708.
89. Persson J, Lindbaeck J, Hofman-Bang C, et al. Efficacy and safety of clopidogrel after PCI with stenting in
patients on oral anticoagulants with acute coronary syndrome. Euro Intervention 2011, 6:1046–1052.
90. Guasch E, Sionis A, Reverter JC, et al. Safety issues of adjunctive clopidogrel in patients discharged after
percutaneous coronary intervention with stent placement and requiring oral anticoagulation. Int J Cardiol 2011,
146:e1–e4.
91. Jang S-W, Rho T-H, Kim D-B, et al. Optimal antithrombotic strategy in patients with atrial fibrillation after
coronary stent implantation. Korean Circ J 2011, 41:578–582.
92. Rubboli A, Magnavacchi P, Guastaroba P, et al. Antithrombotic management and 1-year outcome of patients
on oral anticoagulation undergoing coronary stent implantation (from the registro regionale angioplastiche emiliaromagna registry). Am J Cardiol 2012; 109: 1411-1417.
93. Fosbol EL, Wang TY, Li S, et al. Safety and effectiveness of antithrombotic strategies in older adult patients with
atrial fibrillation and non-ST elevation myocardial infarction. Am Heart J. 2012 Apr;163(4):720-8.